Fast-track Vs. Delayed Insertion of the Levonorgestrel-releasing Intrauterine System After Early Medical Abortion - a Randomized Trial
Overview
Affiliations
Objective: To compare levonorgestrel (LNG) 52-mg intrauterine system (IUS) expulsion rates with fast-track (≤3 days) or delayed (2-4 weeks) insertion following mifepristone and misoprostol medical abortion.
Study Design: In this pilot trial, we randomized 108 women at ≤63 days' gestation to fast-track (n=55) or delayed (n=53) insertion. Follow-up visits occurred at 2-4 weeks, 3 months and 1 year. We assessed total and partial expulsion at 3 months and 1 year, adverse effects and bleeding profiles.
Results: We had follow-up data at 3 months and 1 year for 41 (74.5%) and 37 (69.8%) women in the fast-track group and 31 (56.4%) and 28 (52.8%) women in the delayed group. By 3 months, expulsion occurred in six (12.5%) women after fast-track and one (2.3%) woman after delayed insertion [risk ratio (RR) 5.50, 95% confidence interval (CI) 0.69-43.90]; most (n=5) of these were partial expulsions in the fast-track group. By 1 year, expulsion had occurred in seven (14.6%) and five (11.5%) women in the fast-track and delayed groups, respectively (RR 1.28, 95% CI 0.44-3.75). We found no differences in rates of vacuum aspiration, residual tissue, infection and bleeding or bleeding patterns within 3 months of insertion.
Conclusion: Fast-track insertion of the LNG 52-mg IUS after medical abortion is feasible but may result in higher expulsion rates compared to delayed insertion. Due to lack of statistical power and high lost-to-follow-up rates, we were unable to fully address this question.
Implications: Fast-tract initiation of LNG 52-mg IUS contraception after medical abortion is feasible. It results in higher expulsion rates than delayed insertion but may improve postabortal intrauterine contraception uptake.
Lou Y, Tang S, Sheng Z, Lian H, Yang J, Jin X Sci Rep. 2024; 14(1):11385.
PMID: 38762680 PMC: 11102502. DOI: 10.1038/s41598-024-62327-1.
Hogmark S, Envall N, Gemzell-Danielsson K, Kopp Kallner H Acta Obstet Gynecol Scand. 2023; 102(12):1694-1702.
PMID: 37614066 PMC: 10619601. DOI: 10.1111/aogs.14662.